Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Letter. Mandonnet E. Clin Cancer Res 2024;30:638.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mandonnet E. Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Letter. Clin Cancer Res 2024;30:638.
PMID: 38298141